As response to these drugs varies, the tests help physicians ensure their patients on antiplatelet medications are receiving the optimal benefit.
“We’re extremely excited to continue with the global expansion of our distribution strategy for the VerifyNow System. Accumetrics has chosen each of these partners based on their demonstrated expertise and knowledge of our markets in their respective territories,” said Timothy I. Still, president and chief executive officer.
“These partnerships demonstrate our ongoing expansion of our distribution channels outside the United States, and support our vision to provide physicians access to critical information for managing their cardiovascular patients on antiplatelet therapies.”
